参考文献/References:
[1] Tran QK. Reciprocality between estrogen biology and calcium signaling in the cardiovascular system[J]. Front Endocrinol (Lausanne),2020,11:568203.
[2] Fernández-Atucha A,Izagirre A,Fraile-Bermúdez AB,et al. Sex differences in the aging pattern of renin-angiotensin system serum peptidases[J]. Biol Sex Differ,2017,8:5.
[3] Toering TJ,Gant CM,Visser FW,et al. Sex differences in renin-angiotensin-aldosterone system affect extracellular volume in healthy subjects[J]. Am J Physiol Renal Physiol,2018,314(5):F873-F878.
[4] Yanes LL,Romero DG,Iles JW,et al. Sexual dimorphism in the renin-angiotensin system in aging spontaneously hypertensive rats[J]. Am J Physiol Regul Integr Comp Physiol,2006,291(2):R383-R390.
[5] Chappell MC. Biochemical evaluation of the renin-angiotensin system:the good,bad,and absolute?[J]. Am J Physiol Heart Circ Physiol,2016,310(2):H137-H152.
[6] Huang CC,Chung CM,Leu HB,et al. Sex difference in sympathetic nervous system activity and blood pressure in hypertensive patients[J]. J Clin Hypertens(Greenwich),2021,23(1):137-146.
[7] Contoreggi NH,Mazid S,Goldstein LB,et al. Sex and age influence gonadal steroid hormone receptor distributions relative to estrogen receptor β-containing neurons in the mouse hypothalamic paraventricular nucleus[J]. J Comp Neurol,2021,529(9):2283-2310.
[8] Subhashri S,Pal P,Pal GK,et al. Decreased baroreflex sensitivity is associated with cardiometabolic risks and prehypertension status in early-postmenopausal women[J]. Clin Exp Hypertens,2021,43(2):112-119.
[9] Xue B,Zhang Z,Beltz TG,et al. Estrogen receptor-β in the paraventricular nucleus and rostroventrolateral medulla plays an essential protective role in aldosterone/salt-induced hypertension in female rats[J]. Hypertension,2013,61(6):1255-1262.
[10] Lagunas N,Marraudino M,de Amorim M,et al. Estrogen receptor beta and G protein-coupled estrogen receptor 1 are involved in the acute estrogenic regulation of arginine-vasopressin immunoreactive levels in the supraoptic and paraventricular hypothalamic nuclei of female rats[J]. Brain Res,2019,1712:93-100.
[11] Fu Q. Sex differences in sympathetic activity in obesity and its related hypertension[J]. Ann N Y Acad Sci,2019,1454(1):31-41.
[12] Moreira-Pais A,Ferreira R,Neves JS,et al. Sex differences on adipose tissue remodeling:from molecular mechanisms to therapeutic interventions[J]. J Mol Med (Berl),2020,98(4):483-493.
[13] Link JC,Reue K. Genetic basis for sex differences in obesity and lipid metabolism[J]. Annu Rev Nutr,2017,37:225-245.
[14] Jeffery E,Wing A,Holtrup B,et al. The adipose tissue microenvironment regulates depot-specific adipogenesis in obesity[J]. Cell Metab,2016,24(1):142-150.
[15] Díaz A,López-Grueso R,Gambini J,et al. Sex differences in age-associated type 2 diabetes in rats-role of estrogens and oxidative stress[J]. Oxid Med Cell Longev,2019,2019:6734836.
[16] Posa A,Szabó R,Kupai K,et al. Cardioprotective effect of selective estrogen receptor modulator raloxifene are mediated by heme oxygenase in estrogen-deficient rat[J]. Oxid Med Cell Longev,2017,2017:2176749.
[17] Nevzati E,Shafighi M,Bakhtian KD,et al. Estrogen induces nitric oxide production via nitric oxide synthase activation in endothelial cells[J]. Acta Neurochir Suppl,2015,120:141-145.
[18] Xu R,Huang F,Wang Y,et al. Gender- and age-related differences in homocysteine concentration:a cross-sectional study of the general population of China[J]. Sci Rep,2020,10(1):17401.
[19] Hildreth KL,Ozemek C,Kohrt WM,et al. Vascular dysfunction across the stages of the menopausal transition is associated with menopausal symptoms and quality of life[J]. Menopause,2018,25(9):1011-1019.
[20] Riedel K,Deussen AJ,Tolkmitt J,et al. Estrogen determines sex differences in adrenergic vessel tone by regulation of endothelial β-adrenoceptor expression[J]. Am J Physiol Heart Circ Physiol,2019,317(2):H243-H254.
[21] 王庭槐. 雌激素抑制血管损伤反应的细胞内信号转导机制[C]//湖南省生理科学会. 中南地区第八届生理学学术大会论文摘要汇编.长沙:2012:16-18.
[22] Corcoran MP,Lichtenstein AH,Meydani M,et al. The effect of 17β-estradiol on cholesterol content in human macrophages is influenced by the lipoprotein milieu[J]. J Mol Endocrinol,2011,47(1):109-117.
[23] Kuneman JH,Singh GK,Milhorini Pio S,et al. Sex differences in left ventricular remodelling in patients with severe aortic valve stenosis[J]. Eur Heart J Cardiovasc Imaging,2022,23(6):781-789.
[24] Regitz-Zagrosek V,Kararigas G. Mechanistic pathways of sex differences in cardiovascular disease[J]. Physiol Rev,2017,97(1):1-37.
[25] de Kat AC,Dam V,Onland-Moret NC,et al. Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study[J]. BMC Med,2017,15(1):2.
[26] Chen Y,Zhang Z,Hu F,et al. 17β-estradiol prevents cardiac diastolic dysfunction by stimulating mitochondrial function:a preclinical study in a mouse model of a human hypertrophic cardiomyopathy mutation[J]. J Steroid Biochem Mol Biol,2015,147:92-102.
[27] Wu J,Dai F,Li C,et al. Gender differences in cardiac hypertrophy[J]. J Cardiovasc Transl Res,2020,13(1):73-84.
[28] Carrero JJ,Hecking M,Chesnaye NC,et al. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease[J]. Nat Rev Nephrol,2018,14(3):151-164.
[29] Fanelli C,Dellê H,Cavaglieri RC,et al. Gender differences in the progression of experimental chronic kidney disease induced by chronic nitric oxide inhibition[J]. Biomed Res Int,2017,2017:2159739.
[30] Kattah AG,Smith CY,Gazzuola Rocca L,et al. CKD in patients with bilateral oophorectomy[J]. Clin J Am Soc Nephrol,2018,13(11):1649-1658.
[31] Ichii O,Nakamura T,Irie T,et al. Close pathological correlations between chronic kidney disease and reproductive organ-associated abnormalities in female cotton rats[J]. Exp Biol Med (Maywood),2018,243(5):418-427.
[32] Sánchez DS,Fischer Sigel LK,Azurmendi PJ,et al. Estradiol stimulates cell proliferation via classic estrogen receptor-alpha and G protein-coupled estrogen receptor-1 in human renal tubular epithelial cell primary cultures[J]. Biochem Biophys Res Commun,2019,512(2):170-175.
[33] Cobo G,Hecking M,Port FK,et al. Sex and gender differences in chronic kidney disease:progression to end-stage renal disease and haemodialysis[J]. Clin Sci (Lond),2016,130(14):1147-1163.
[34] Park YJ,Kim JM. Klotho and postmenopausal hormone replacement therapy in women with chronic kidney disease[J]. J Menopausal Med,2018,24(2):75-80.
[35] Weinstein JR,Anderson S. The aging kidney:physiological changes[J]. Adv Chronic Kidney Dis,2010,17(4):302-307.
相似文献/References:
[1]孙刚,黄冠华,综述.高血压合并心力衰竭的治疗策略[J].心血管病学进展,2016,(2):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
SUN Gang,HUANG Guanhua.Treatment Strategy of Hypertension with Heart Failure[J].Advances in Cardiovascular Diseases,2016,(8):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
[2]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(8):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[3]陈源源.钙通道阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,(6):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
CHEN Yuanyuan.Application of Calcium Channel Blockers in Hypertension Treatment[J].Advances in Cardiovascular Diseases,2015,(8):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
[4]张瑞 毛露 孙硕 Dirk Hermann 陈艾东.内皮素-1干预成为高血压治疗新靶点的展望[J].心血管病学进展,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
ZHANG Rui MAO LuSUN ShuoDIRK Hermann CHEN Aidong.The Prospect of Endothelin-1 Intervention as A New Target for the Treatment of Hypertension[J].Advances in Cardiovascular Diseases,2019,(8):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
[5]张毅,柳志红.动态血压监测在高血压中的应用现状与问题[J].心血管病学进展,2019,(6):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
ZHANG Yi,LIU Zhihong.Current status and nsolved Pproblems of Ambulatory Blood Pressure Monitoring for the Management of Hypertension[J].Advances in Cardiovascular Diseases,2019,(8):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
[6]黄秋瑾 胡蓉.高血压合并糖尿病患者血压控制率和控制目标的探讨[J].心血管病学进展,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
HUANG QiujinHU Rong.Discussion on Blood Pressure Control Rate and Control Target in Patients with Hypertension Complicated with Diabetes[J].Advances in Cardiovascular Diseases,2019,(8):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
[7]张旭明 王曦.高血压对认知功能的影响[J].心血管病学进展,2019,(7):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
ZHANG Xuming,WANG Xi.The Relationship Between Hypertension and Cognitive Function[J].Advances in Cardiovascular Diseases,2019,(8):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
[8]程晓艺,寇秀玲,黄明刚,等.颈动脉斑块与冠状动脉粥样硬化相关性影像学分析[J].心血管病学进展,2019,(6):960.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.030]
CHENG Xiaoyi,KOU Xiuling,HUANG Minggang,et al.Imaging Analysis of Carotid Plaque and Coronary Artery Atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(8):960.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.030]
[9]凌梦军 陈明凌梦军.阻塞性睡眠呼吸暂停低通气综合征与高血压关系的研究进展[J].心血管病学进展,2019,(5):722.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.015]
[10]李波 郭毅 田进文 邓珏琳.高血压合并2型糖尿病的治疗进展[J].心血管病学进展,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
LI Bo,GUO Yi,TIAN Jinwen,et al.Therapy in Hypertensive Patients with Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(8):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]